CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

Yongxian Hu, Jingjing Li, Fang Ni, +16

Nature Communications

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

Ruimin Hong, Elaine Tan Su Yin, Linqin Wang, +13

Frontiers in Oncology

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Linqin Wang, Ruimin Hong, Linghui Zhou, +9

Frontiers in Oncology

Mixed-phenotype Acute LeukemiaImmunologyImmunotherapyHematological MalignancyBone Marrow Failure +15

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study

Yongxian Hu, Cheng Zu, Mingming Zhang, +12

EClinicalMedicine

Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy

Ruimin Hong, Houli Zhao, Yiyun Wang, +5

Bone Marrow Transplantation

CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells

Linqin Wang, Yiyun Wang, Xiangjun He, +21

Cell Reports Medicine

Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment

Linghui Zhou, Houli Zhao, Yang Shao, +7

Journal of Cancer

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

Lijuan Ding, Yiyun Wang, Ruimin Hong, +11

Frontiers in Oncology

Cell TherapyImmunologyTransplantation MedicinePost-transplant RelapseCell Replacement Therapy +19

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Mingming Zhang, Shan Fu, Jingjing Feng, +23

JAMA Oncology

Derivation and validation of a novel score for early prediction of severe <scp>CRS</scp> after <scp>CAR‐T</scp> therapy in haematological malignancy patients: A multi‐centre study

Linghui Zhou, Weijun Fu, Shenghao Wu, +22

British Journal of Haematology